Sponsored Links

Gout
Title Filter     Display # 
# Article Title
1 TMX-67 (Febuxostat) Approved In Japan - Teijin-Developed Novel Drug For Chronic Management Of Hyperuricemia
2 Seniors Group Asks Medicare Part-D Plans To Provide Affordable Gout Medication For Patients
3 Teijin Pharma Expands Global Market For TMX-67 (febuxostat) - Turkey, Mexico, Caribbean, Middle East And North Africa
4 New Survey Reveals Most Americans Unaware Of Gout Risk Factors, In The Dark About Connection To Diabetes, Kidney Disease, And Cardiac Problems
5 Got The Gout? Novartis Sees Positive Results From Ilaris Treatment
6 Additional Results From A Phase 2b Study Of Lesinurad In Combination With Allopurinol
7 The True Burden Of Gout And Promising New Treatments
8 BioCryst Presents New Analyses Of BCX4208 Phase 2 Studies In Patients With Gout At The Annual European Congress Of Rheumatology
9 Lower Doses Of Anti-Gout Drug Recommended
10 Arthritis Foundation And Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign
11 Krystexxa (pegloticase) Approved For Treatment Of Gout
12 BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined With Allopurinol In Patients With Gout
13 FDA Orders Halt To Marketing Of Unapproved Single-ingredient Oral Colchicine
14 Nuon Therapeutics Announces Gout Program Study Results To Be Presented At The American College Of Rheumatology
15 TMX-67 (ULORIC(r)) Launches In Canada - Novel Drug For Chronic Management Of Hyperuricemia In Gout Patients
16 Cegedim Strategic Data (CSD) Evaluates The Importance Of Cooperation Between GPs And Specialists For Gout Disease Management
17 Gout In Women, A Not So Sweet Outcome Of Sugar-Sweetened Drinks
18 Anti-Gout Drug May Decrease Risk For Colorectal Adenoma Progression
19 The Number Of People With Gout Continues To Rise
20 Urate Lowering Therapy Could Prevent Death Associated With Cardiovascular Disease In People With Gout
 
<< Start < Prev 1 2 3 4 Next > End >>
Page 1 of 4
Copyright (C) 2009 MedicalMarket.info